-P Altevogt Researcher Activity Profile

Research Author Detailed Information 

P Altevogt Publication Rate By Year

P Altevogt has published 1 paper(s) in 2004, 10 paper(s) in 2007, 3 paper(s) in 2008, for a total of 14 research publications in total.

P P Altevogt Author Information

LAST NAME: altevogt

FIRST NAME: P

INITIALS: p

AFFILIATION:

Papers

P Altevogt's Publication Record

1. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Year Published: 2007
Tumor Immunology Programme, German Cancer Research Center, Heidelberg, Germany.
2. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Year Published: 2007
Tumor Immunology Programme, German Cancer Research Center, Heidelberg, Germany.
3. The role of L1 in the progression of ovarian carcinomas. Year Published: 2004
Tumor Immunology Programme, D010, German Cancer Research Center, Heidelberg, Germany. p.altevogt@dkfz.de
4. The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Year Published: 2008
Tumor Immunology Programme, German Cancer Research Center, Heidelberg, Germany.
5. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Year Published: 2007
Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong, China.
6. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Year Published: 2007
7. CD24 induces localization of beta1 integrin to lipid raft domains. Year Published: 2007
Tumor Immunology Programme, D010, German Cancer Research Center, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
8. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Year Published: 2007
Tumor Immunology Programme (D010), German Cancer Research Center, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
9. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Year Published: 2007
Tumor Immunology Programme (D010), German Cancer Research Center, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
10. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Year Published: 2007
11. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Year Published: 2007
Tumor Immunology Programme (D010), German Cancer Research Center, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
12. CD24 induces localization of beta1 integrin to lipid raft domains. Year Published: 2007
Tumor Immunology Programme, D010, German Cancer Research Center, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
13. Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion. Year Published: 2008
Tumor Immunology Program, German Cancer Research Center (DKFZ), D010/TP3, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
14. Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion. Year Published: 2008
Tumor Immunology Program, German Cancer Research Center (DKFZ), D010/TP3, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.